Condition (MeSH)
Dermatitis, Exfoliative
ClinicalTrials.gov lists 2 trials for Dermatitis, Exfoliative or a narrower condition beneath it. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Dermatitis, Exfoliative itself; the rest are tagged with a narrower condition beneath it.
When did Dermatitis, Exfoliative trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2009 | 1 |
| 1994 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dermatitis, Exfoliative trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 1 |
| Observational | 1 |
How many Dermatitis, Exfoliative trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Dermatitis, Exfoliative trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
Which publications cover Dermatitis, Exfoliative? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Peeling Skin Disorders: A Paradigm for Skin Desquamation. | The Journal of investigative dermatology | 2018 | Yes |
| Unusual dermatological presentation and immune phenotype in SCID due to an IL7R mutation: the value of whole-exome sequencing and the potential benefit of newborn screening. | Journal of the European Academy of Dermatology and Venereology : JEADV | 2017 | Yes |
| [Exfoliative dermatitis as a side effect of intravenous immunoglobulin treatment]. | Ugeskrift for laeger | 2011 | Yes |
| Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. | Journal of the American Academy of Dermatology | 2002 | Yes |
| Quantifying systemic absorption of topical hydrocortisone in erythroderma. | The British journal of dermatology | 1995 | Yes |
Showing 5 of 9 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.